GIM
WST icon

Glenmede Investment Management’s West Pharmaceutical WST Stock Holding History

Glenmede Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.1M Sell
4,201
-967
-19% -$235K 0.01% 680
2025
Q2 		$1.13M Buy
+5,168
New +$1.1M 0.01% 682

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Glenmede Investment Management's WST Position: Q3 2025 in Review

Glenmede Investment Management reduced its West Pharmaceutical (WST) stake by 19% in Q3 2025, selling an estimated $235K and leaving 4,201 shares worth $1.1M. The position accounts for 0.01% of the portfolio, ranked #680.

Glenmede Investment Management first reported a position in WST in Q2 2025 and has held it in 2 quarters since. The position peaked at $1.13M in Q2 2025. 756 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Glenmede Investment Management held 4,201 shares of West Pharmaceutical worth $1.1M as of Q3 2025.
  • Glenmede Investment Management sold 967 West Pharmaceutical shares in Q3 2025, an estimated $235K.
  • West Pharmaceutical made up 0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #680 holding.
  • Glenmede Investment Management first reported a position in West Pharmaceutical in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's West Pharmaceutical position peaked at $1.13M in Q2 2025.
  • 756 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.